Haihe Biopharma Co., Ltd.
Clinical trials sponsored by Haihe Biopharma Co., Ltd., explained in plain language.
-
New pill tested for aggressive blood cancer after other treatments fail
Disease control Recruiting nowThis study is testing an oral drug called HH2853 for people with a type of blood cancer called peripheral T-cell lymphoma that has come back or hasn't responded to previous treatments. The goal is to find a safe and effective dose and to see if the drug can help control the cance…
Phase: PHASE1, PHASE2 • Sponsor: Haihe Biopharma Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug trial targets root cause of rare, painful growth disorders
Disease control Recruiting nowThis early-stage study is testing an experimental drug called CYH33 for people with rare disorders that cause abnormal tissue and blood vessel overgrowth (PROS and PRVM). The main goals are to find a safe dose and see if the drug can shrink the overgrown lesions by at least 20% a…
Phase: PHASE1, PHASE2 • Sponsor: Haihe Biopharma Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New pill tested in fight against Tough-to-Treat cancers
Disease control Recruiting nowThis early-stage study is testing a new oral medication called HH2853 in adults with advanced cancers that have come back or stopped responding to standard treatments. The main goals are to find a safe and tolerable dose and to see if the drug shows any early signs of helping to …
Phase: PHASE1, PHASE2 • Sponsor: Haihe Biopharma Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC